Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Polymerase Chain Reaction 4Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Light Coagulation 2Cytogenetic Analysis 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Busulfan 2alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Soybean Proteins 1Rosuvastatin Calcium 1Paclitaxel 1Moxifloxacin 1Morphine 1Microarray Analysis 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Precancerous Conditions × Vaginal Smears × Clear all
NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

GOG Foundation

Phase NA Completed
684 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡